Donaldson (NYSE: DCI) director reports 100 shares and 200-share option award
Rhea-AI Filing Summary
Donaldson Company director reports new stock and option awards. Director Daniel P. Shine acquired 100 shares of Donaldson Company common stock on December 8, 2025, reported at a price of $0, bringing his directly held common shares to 100 after the transaction. On the same date, he was also granted a stock option to buy 200 shares of common stock at an exercise price of $91.76 per share, expiring on December 8, 2035.
The option vests in three equal annual installments beginning on December 8, 2026, meaning the right to exercise is spread over three years. Following these awards, Shine directly holds 200 stock options in addition to the 100 common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 200 | $0.00 | -- |
| Grant/Award | Common Stock | 100 | $0.00 | -- |
Footnotes (1)
- [object Object]
FAQ
What insider transaction was reported for Donaldson Co (DCI)?
Director Daniel P. Shine reported acquiring 100 shares of Donaldson Company common stock and receiving a stock option for 200 shares on December 8, 2025.
What are the key terms of the new Donaldson (DCI) stock option grant?
The grant is a stock option to buy 200 shares of Donaldson common stock at an exercise price of $91.76 per share, expiring on December 8, 2035.
How does the Donaldson (DCI) stock option for Daniel P. Shine vest?
The option vests in three equal annual installments beginning on December 8, 2026, spreading the exercisable portions over three years.
Was the Donaldson (DCI) stock acquired for cash in this Form 4?
The 100 shares of common stock are reported at a price of $0, indicating they were not purchased for cash in the market.
What is the relationship of the reporting person to Donaldson (DCI)?
The reporting person, Daniel P. Shine, is identified as a Director of Donaldson Company.